ADM issued a press release just last week about the forthcoming publication, in which Daniel Ramon Vidal, the company’s vice president of health and wellness R&D, remarked, “We are excited about the results, and the potential for our probiotic blend, an original and optimal nutritional supplement, to enhance the action of pharmacological agents used in the treatment of psoriasis, as well as lowering the risk of relapse, as was seen in patients receiving the combined treatment.”
Further knowledge of the gut-skin axis
The company has been working towards a probiotic supplement that addresses topical symptoms for some time; and this latest study brings an ADM skin treatment supplement closer to market.
“Based on preliminary data obtained two years ago, highlighting the link between changes in the gut microbiome and the development of psoriasis, ADM began to formulate and research the use of probiotics in psoriasis patients for preventing the development of the disease or increasing the effectiveness of current therapeutic treatments,” explains the press release.
ADM conducted clinical research to assess the advantages of incorporating probiotic supplements in a corticosteroids psoriasis treatment regimen. The test compared the relapse rate and severity—over 6 months—of patients treated with corticosteroids and a placebo ‘supplement’ to patients treated with corticosteroids and a probiotic supplement.
Lactobacillus continues to be a go-to microbe
According to Lumina Intelligence data from December 2018, Lactobacillus strains account for all of the top 5 “most common species in probiotic cosmetics.” (as Cosmetics Design has previously reported). So that strain is quickly becoming a ‘good bacteria’ in the eyes of today’s ingredient-conscious consumers.
And that fact makes ADM’s research all the more market ready: “The mixture of probiotics, developed by ADM Biopolis, in conjunction with Korott and Bionou, consists of two strains of bifidobacteria and one strain of lactobacillus, which are known to exert anti-inflammatory and antioxidant properties,” as the press release states.
Are consumers ready for bacteria as medicine?
If headlines here on Cosmetics Design are any indication, probiotic skin care products and beauty supplements are both here to stay. In the last few months Nestlé acquired the Persona supplement business (and Persona added beauty supplements to its portfolio in 2018); in the Korea market, Amorepacific launched a beauty supplement brand called CUBEME; here in the States, The Vitamin Shoppe recently launched a personalized supplement subscription service that includes pills with beauty benefits; and the list goes on.
And not only are probiotic and prebiotic skin care products now common on store shelves and ecommerce sites, new microbiome beauty ingredients are coming to market. At this month’s SCC Suppliers’ Day tradeshow in Long Beach, California, companies like CLR, Amerilure, bitop, and Solabia were showing microbiome beauty ingredients.
Solabia (as Cosmetics Design reported just last week in a trends article about Suppliers' Day) “was featuring its SansiScalp ingredient (for anti-dandruff, sensitive scalp, and hair styling applications) and also showing BioEcolia, EcoSkin, and Teflose as other microbiome beauty options.”
And probiotic beauty brands like Tula and Bebe & Bella sell both topical probiotics and probiotic supplements to consumers looking for skin wellness benefits. All of which strongly suggests that consumers are more than ready to start thinking about probiotics as medicine.
Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.